NCT00354835 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 239
- group Id
- BG001
- value
- 242
- group Id
- BG002
- value
- 481
- units
- Participants
- groups
- description
- Patients receive VAC chemotherapy comprising vincristine IV over 1 minute on day 1 of weeks 1-13, 16, 19-25, 28, 31-37, and 40; dactinomycin IV over 1-5 minutes on day 1 of weeks 1, 4, 13, 16, 19, 22, 25, 28, 31, 34, 37,and 40; and cyclophosphamide IV over 1 hour on day 1 of weeks 1, 4, 7, 10, 13, 16, 19, 22, 25, 28, 31, 34, 37, and 40. Patients may also undergo radiotherapy 5 days a week for 4-6 weeks beginning in week 4.
- id
- BG000
- title
- Vincristine, Dactinomycin, Cyclophosphamide (VAC)
- description
- Patients receive VAC chemotherapy alternating with VI chemotherapy comprising vincristine IV over 1 minute on day 1 of weeks 1-13, 16, 17, 19, 20, 22-26, 28, 31-34, 37, 38, and 40; dactinomycin IV over 1-5 minutes on day 1 of weeks 1, 13, 22, 28, 34, and 40; cyclophosphamide IV over 1 hour on day 1 of weeks 1,10, 13, 22, 28, 34, and 40; and irinotecan hydrochloride IV over 1 hour on days 1-5 of weeks 4, 7, 16, 19, 25, 31, and 37. Patients may also undergo radiotherapy 5 days a week for 4-6 weeks beginning in week 4.
- id
- BG001
- title
- VAC Alternating With Vincristine, Irinotecan (VI)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 73.39
- value
- 89.85
- group Id
- BG001
- spread
- 82.66
- value
- 97.86
- group Id
- BG002
- spread
- 78.21
- value
- 93.88
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 109
- group Id
- BG001
- value
- 113
- group Id
- BG002
- value
- 222
- title
- Female
- measurements
- group Id
- BG000
- value
- 130
- group Id
- BG001
- value
- 129
- group Id
- BG002
- value
- 259
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 67
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 191
- group Id
- BG001
- value
- 204
- group Id
- BG002
- value
- 395
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 19
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 14
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 66
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 165
- group Id
- BG001
- value
- 181
- group Id
- BG002
- value
- 346
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 51
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 239
- group Id
- BG001
- value
- 242
- group Id
- BG002
- value
- 481
- units
- Participants
- groups
- description
- Patients receive VAC chemotherapy comprising vincristine IV over 1 minute on day 1 of weeks 1-13, 16, 19-25, 28, 31-37, and 40; dactinomycin IV over 1-5 minutes on day 1 of weeks 1, 4, 13, 16, 19, 22, 25, 28, 31, 34, 37,and 40; and cyclophosphamide IV over 1 hour on day 1 of weeks 1, 4, 7, 10, 13, 16, 19, 22, 25, 28, 31, 34, 37, and 40. Patients may also undergo radiotherapy 5 days a week for 4-6 weeks beginning in week 4.
- id
- BG000
- title
- Vincristine, Dactinomycin, Cyclophosphamide (VAC)
- description
- Patients receive VAC chemotherapy alternating with VI chemotherapy comprising vincristine IV over 1 minute on day 1 of weeks 1-13, 16, 17, 19, 20, 22-26, 28, 31-34, 37, 38, and 40; dactinomycin IV over 1-5 minutes on day 1 of weeks 1, 13, 22, 28, 34, and 40; cyclophosphamide IV over 1 hour on day 1 of weeks 1,10, 13, 22, 28, 34, and 40; and irinotecan hydrochloride IV over 1 hour on days 1-5 of weeks 4, 7, 16, 19, 25, 31, and 37. Patients may also undergo radiotherapy 5 days a week for 4-6 weeks beginning in week 4.
- id
- BG001
- title
- VAC Alternating With Vincristine, Irinotecan (VI)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 73.39
- value
- 89.85
- group Id
- BG001
- spread
- 82.66
- value
- 97.86
- group Id
- BG002
- spread
- 78.21
- value
- 93.88
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- value
- 109
- group Id
- BG001
- value
- 113
- group Id
- BG002
- value
- 222
- title
- Female
- measurements
- group Id
- BG000
- value
- 130
- group Id
- BG001
- value
- 129
- group Id
- BG002
- value
- 259
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 67
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 191
- group Id
- BG001
- value
- 204
- group Id
- BG002
- value
- 395
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 19
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 14
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 29
- group Id
- BG002
- value
- 66
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 165
- group Id
- BG001
- value
- 181
- group Id
- BG002
- value
- 346
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 51
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle